- Home
- QNRX vs NBY Comparison
QNRX vs NBY Comparison
Compare QNRX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- NBY
- Stock Information
- Founded
- QNRX 2018
- NBY 2000
- Country
- QNRX United States
- NBY United States
- Employees
- QNRX N/A
- NBY N/A
- Industry
- QNRX Medical/Dental Instruments
- NBY
- Sector
- QNRX Health Care
- NBY
- Exchange
- QNRX Nasdaq
- NBY Nasdaq
- Market Cap
- QNRX 2.5M
- NBY N/A
- IPO Year
- QNRX N/A
- NBY 2007
- Fundamental
- Price
- QNRX $0.24
- NBY $0.61
- Analyst Decision
- QNRX
- NBY Strong Buy
- Analyst Count
- QNRX 0
- NBY 1
- Target Price
- QNRX N/A
- NBY $0.85
- AVG Volume (30 Days)
- QNRX 567.3K
- NBY 51.6K
- Earning Date
- QNRX 03-13-2025
- NBY 05-08-2025
- Dividend Yield
- QNRX N/A
- NBY N/A
- EPS Growth
- QNRX N/A
- NBY N/A
- EPS
- QNRX N/A
- NBY N/A
- Revenue
- QNRX N/A
- NBY $13,844,000.00
- Revenue This Year
- QNRX N/A
- NBY N/A
- Revenue Next Year
- QNRX N/A
- NBY $11.73
- P/E Ratio
- QNRX N/A
- NBY N/A
- Revenue Growth
- QNRX N/A
- NBY 15.40
- 52 Week Low
- QNRX $0.24
- NBY $0.36
- 52 Week High
- QNRX $1.57
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- QNRX 32.92
- NBY 46.58
- Support Level
- QNRX $0.28
- NBY $0.60
- Resistance Level
- QNRX $0.32
- NBY $0.64
- Average True Range (ATR)
- QNRX 0.02
- NBY 0.03
- MACD
- QNRX 0.00
- NBY 0.00
- Stochastic Oscillator
- QNRX 2.31
- NBY 31.11
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.